急性心源性肺水肿(ACOE)是常见内科急危重症,多数能通过给氧和药物治疗得以纠正,但也有不少患者疗效不佳,出现严重的呼吸衰竭,需要机械通气。传统气管插管创伤大,有很多风险和不良后果。随着无创通气技术在临床上的广泛应用,被用于救治心源性肺水肿的报道日益增多,但一直存在争议,不少医务人员仍持观望、怀疑态度。本院急诊科应用 BIPAP 无创正压通气(NIPPV)已治疗12例重症心源性肺水肿(APE)病人,报道于下。 Acute cardioembolic pulmonary edema (ACOE) is a common medical emergency critical illness, most can be corrected by oxygen and medication, but there are many patients with poor efficacy, severe respiratory failure, the need for mechanical ventilation. Traditional tracheal intubation trauma, there are many risks and adverse consequences. With the wide application of noninvasive ventilation technology in clinical practice, the reports of being used to treat cardiogenic pulmonary edema have been increasing. However, there are still controversies. Many medical workers still hold wait and see attitude. In our emergency department, 12 patients with severe acute cardiogenic pulmonary edema (APE) treated with BIPAP noninvasive positive pressure ventilation (NIPPV) were reported below.